![Michael Milligan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Milligan
Finansdirektör/CFO på
NEUMORA THERAPEUTICS, INC.
Förmögenhet: 38 913 $ per 2026-05-31
Profil
Michael Lee Milligan is currently Chief Financial Officer & Executive Vice President at New Haven Pharmaceuticals, Inc. and Chief Financial & Accounting Officer at Neumora Therapeutics, Inc. Former positions include Vice President Finance & Controller at Y-mAbs Therapeutics, Inc., Vice President-Finance & Controller at Acorda Therapeutics, Inc., and Chief Accounting Officer & Vice President at Shionogi, Inc. Education includes an MBA from Georgia State University and an undergraduate degree from the University of Miami.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-02-17 | 21 034 ( 0,01 % ) | 38 913 $ | 2026-05-31 |
Aktiva positioner av Michael Milligan
| Företag | Position | Start |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Finansdirektör/CFO | 2025-02-14 |
New Haven Pharmaceuticals, Inc.
 New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops new prescription drug products | Finansdirektör/CFO | - |
Tidigare kända positioner av Michael Milligan
| Företag | Position | Slut |
|---|---|---|
| ACORDA THERAPEUTICS, INC. | Comptroller/Controller/Revisor | - |
Shionogi, Inc.
 Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Comptroller/Controller/Revisor | - |
| YMAS THER | Comptroller/Controller/Revisor | - |
Michael Milligans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
9
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Acorda Therapeutics, Inc.
 Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Georgia State University
 Georgia State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops new prescription drug products | Health Technology |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Health Technology |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
